Effects on Pruritus and Sleep Disturbance in Patients with Primary Biliary Cholangitis (PBC) after 1 Year of Treatment with Seladelpar, a Peroxisome Proliferator-Activated Receptor Delta Agonist: Results of an Open-label Phase 2 Study Uploaded: Jun 23, 2020 Type: PDF
Effects on Pruritus and Sleep Disturbance in Patients with Primary Biliary Cholangitis (PBC) after 1 Year of Treatment with Seladelpar, a Peroxisome Proliferator-Activated Receptor Delta Agonist: Results of an Open-label Phase 2 Study Uploaded: Jun 19, 2020 Type: Video
Shareholder Letter Uploaded: Jan 29, 2020 Type: PDF
Structural and Biophysical Characterization of the Origins of the PPAR Selectivity of Seladelpar and Elafibranor, Peroxisomal Proliferator Activated Receptor (PPAR) Agonists Targeting Inflammatory Liver Diseases Uploaded: Nov 11, 2019 Type: PDF
Pharmacokinetics of Seladelpar in Patients with Primary Biliary Cholangitis (PBC) with or without Cirrhosis Uploaded: Nov 9, 2019 Type: PDF
